Skip Nav Destination
PDUFA Pending
A quick look at hematologic drugs pending approval by the U.S. Food and Drug Administration
FDA to Give Narsoplimab Second Look for Treatment of HSCT-Associated Thrombotic Microangiopathy
Free
July 31, 2025
July 31, 2025
July 16, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
February 26, 2025
February 26, 2025
Advertisement intended for health care professionals
Connect with us:
CURRENT ISSUE
July 2025
Advertisement intended for health care professionals
